Non-alcoholic Fatty Liver Disease: From Steatosis to Cirrhosis

Farrell, GeoffreyLarter, Claire2015-12-100270-9139http://hdl.handle.net/1885/57331Nonalcoholic steatohepatitis (NASH), the lynchpin between steatosis and cirrhosis in the spectrum of nonalcoholic fatty liver disorders (NAFLD), was barely recognized in 1981. NAFLD is now present in 17% to 33% of Americans, has a worldwide distribution,Keywords: alpha tocopherol; ascorbic acid; betaine; cytokine; glitazone derivative; metformin; pentoxifylline; peroxisome proliferator activated receptor alpha agonist; peroxisome proliferator activated receptor gamma agonist; pioglitazone; placebo; rosiglitazone;Non-alcoholic Fatty Liver Disease: From Steatosis to Cirrhosis200610.1002/hep.209732015-12-09